About Instituto Cardiovascular de Buenos Aires-ICBA
"Centro médico cardiológico especialistas de corazón"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Instituto Cardiovascular de Buenos Aires-ICBA
During the past decade, Instituto Cardiovascular de Buenos Aires-ICBA conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on
average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Instituto Cardiovascular de Buenos Aires-ICBA" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Amgen" with 2 trials
sponsored, "Bayer" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Cardiovascular de Buenos Aires-ICBA"
#1 collaborator was "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Swiss National Science Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Instituto Cardiovascular de Buenos Aires-ICBA
According to Clinical.Site data, the most researched conditions in "Instituto Cardiovascular de Buenos Aires-ICBA" are
"Atrial Fibrillation" (4 trials), "Coronary Artery Disease" (4 trials), "Cardiovascular Disease" (3 trials), "Coronary Artery Stenosis" (3 trials) and "Myocardial Ischemia" (3 trials). Many other conditions were trialed in "Instituto Cardiovascular de Buenos Aires-ICBA" in a lesser frequency.
Clinical Trials Intervention Types at Instituto Cardiovascular de Buenos Aires-ICBA
Most popular intervention types in "Instituto Cardiovascular de Buenos Aires-ICBA" are "Drug" (8 trials), "Device" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "XIENCE V®/ XIENCE PRIME™" (2 trials), "bococizumab (PF-04950615)" (2 trials), "ABSORB BVS" (1 trials) and "Apabetalone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto Cardiovascular de Buenos Aires-ICBA
The vast majority of trials in "Instituto Cardiovascular de Buenos Aires-ICBA" are
14 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Instituto Cardiovascular de Buenos Aires-ICBA
Currently, there are NaN active trials in "Instituto Cardiovascular de Buenos Aires-ICBA".
undefined are not yet recruiting,
4 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Instituto Cardiovascular de Buenos Aires-ICBA,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto Cardiovascular de Buenos Aires-ICBA, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 3 trials that are defined as “Not Applicable".
Departments of Instituto Cardiovascular de Buenos Aires-ICBA
Instituto Cardiovascular de Buenos Aires-ICBA has several departments that took part in Clinical trials: "Instituto Cardiovascular de Buenos Aires" - 4 trials